Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...

Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little ...

The pathophysiology of intermittent claudication is complex as it involves both a reduction in blood flow to peripheral tissues as well as changes in the metabolic function of skeletal muscle, caused ...

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its ...

PAD typically onsets with no noticeable symptoms. Over time, it can progress and begin causing limb pain and cramping, even when at rest. Early treatment can help to slow the progression and reduce ...

Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...

Drug-coated balloons (DCB) and stents may not reduce the risk of needing a major amputation compared with uncoated devices in patients with chronic limb-threatening ischemia (CLTI) nor improve quality ...